Prof Schmid presents research from a phase Ia expansion study at AACR 2017, evaluating responses to atezolizumab in patients with metastatic triple negative breast cancer. Slides from this presentation are available here. Prof Schmid discussed these...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2osXMww
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Ich konzipiere den in London wirkende Schweizer Maler Heinrich Füssli (Henry Fuseli, 1741-1825) als Klassizist, die eine neue Sichtweise der...
-
A new study among more than 1000 colorectal cancer patients at Dana-Farber Cancer Institute has revealed that a surprising number of patient...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oz7Jcs via IFTTT
-
Write to your politicians, national or local, for free. Over 200,000 messages sent last year. from #AlexandrosSfakianakis via Alexandros G...
-
Publication date: August 2017 Source: International Journal of Biological Macromolecules, Volume 101 Author(s): Toiba Majeed, Idrees Ahme...
-
I'm asked by all of my doctoral students at some point during their writing to give them good dissertation examples. I'm not complai...
-
Vol.24 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1RxFyR3 via IFTTT
-
In utero exposure to radiation and haematological malignancies: pooled analysis of Southern Urals cohorts British Journal of Cancer 116, 12...
-
Purpose: Using gene-disrupted allogeneic T cells as universal effector cells provides an alternative and potentially improves current chime...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου